Strides Arcolab has received approval from the United States Food and Drug Administration (USFDA) for Methoxsalen Capsules, 10 mg (Soft Gelatin Capsules).
Methoxsalen is a drug used to treat psoriasis, eczema, vitiligo and some cutaneous lymphomas in conjunction with exposing the skin to UVA light from lamps or sunlight. Methoxsalen modifies the way skin cells receive the UVA radiation, clearing up the disease.
The product will be manufactured at the company’s USFDA approved oral dosage facility at Bangalore and marketed directly by Strides in the US market.
According to IMS data, the US market for generic Methoxsalen Capsule is approximately $13.6 million, with no generic player.